Position in INSM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,880,519
-$553,981 QoQ
Shares Held
48,193
-0.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $117,481,189 across 42 Biotechnology names. INSM ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,893 | $47,732,000 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,517 | $32,850,334 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,472 | $9,751,400 | |
| 4 | INSM |
INSMED Inc
This page
|
48,193 | $7,880,519 | |
| 5 | INCY |
Incyte Corp
|
42,643 | $4,013,559 | |
| 6 | MRNA |
Moderna, Inc.
|
78,526 | $3,989,120 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,856 | $1,821,574 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,224 | $1,449,845 |
All Filings in INSM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,880,519 | 48,193 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,434,500 | 48,463 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $687,935 | 4,777 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $480,757 | 4,777 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $364,437 | 4,777 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $323,452 | 4,685 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $323,974 | 4,438 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $287,363 | 4,289 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||